The outcome of chemotherapeutic regimen by high-risk pre-B-cell protocol in ALL children
-
Published:2021-07-22
Issue:3
Volume:31
Page:330-333
-
ISSN:2368-8076
-
Container-title:Canadian Oncology Nursing Journal
-
language:
-
Short-container-title:CONJ
Author:
Fathi Afshin,Mirzarahimi Mehrdad,Farajkhah Homa
Abstract
Objective: The aim of this study was to investigate the outcome of chemotherapeutic regimen by high-risk pre-B-cell potocol in ALL children. Methods: The cross-sectional study was conducted on 55 children who were treated with the Children Oncology Group (COG) protocol from September 2010 to February 2015 to evaluate the chemotherapeutic regimen results. Results: There was a complete recovery rate of 76.4% during the first week after treatment. Three-year overall survival was 85.5% and five-year overall survival was 81%. Relapse rate after first remission was 20% and death after relapse was 50%. Thirty percent of total deaths were at the induction period. All of the deceased cases died due to sepsis. Conclusion: Results showed that the survival rate increased. By choosing the COG protocol and by controlling infection in patients without considering the risk group we can improve survival rates.
Publisher
Pappin Communications
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献